Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents

被引:10
作者
Dai, Kazuoki [1 ]
Ishihara, Masaharu [1 ,2 ]
Inoue, Ichiro [1 ]
Kawagoe, Takuji [1 ]
Shimatani, Yuji [1 ]
Miura, Fumiharu [1 ]
Nakama, Yasuharu [1 ]
Otani, Takayuki [1 ]
Ooi, Kuniomi [1 ]
Ikenaga, Hiroki [1 ]
Nakamura, Masayuki [1 ]
Miki, Takashi [1 ]
Kishimoto, Shinji [1 ]
Sumimoto, Yoji [1 ]
机构
[1] Hiroshima City Hosp, Dept Cardiol, Hiroshima, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan
关键词
Angioscopy; Coronary artery disease; Stent; THROMBOSIS; COVERAGE; STENOSIS; PLAQUES; RISK;
D O I
10.1016/j.jjcc.2012.08.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We assessed angioscopic findings after everolimus-eluting stents (EES) implantation, compared with sirolimus-eluting stents (SES). Background: Coronary angioscopy (CAS) provides an opportunity to assess neointimal coverage over stent struts, thrombus, and plaque color by direct visualization. CAS is a useful tool for evaluating stent struts after drug-eluting stent implantation. Angioscopic findings after EES implantation have not been reported before. Methods: We performed CAS in 23 patients who were treated with EES and 41 patients with SES. CAS was performed 8.5 months after stent implantation. We assessed neointimal coverage, thrombus, and plaque color. We classified neointimal coverage in 4 grades: grade 0 = struts were completely exposed; grade 1 = struts were visible with dull light reflexion; grade 2 = there was no light reflexion from slightly visible struts; grade 3 = struts were completely covered. Results: There was no significant difference in minimum, maximum, dominant grade of neointimal coverage, and heterogeneity index between EES and SES. Thrombus was less frequently observed in EES than SES (4% vs 29%, p = 0.02). When we divided study patients into acute coronary syndrome (ACS) or stable angina pectoris (SAP), there was a tendency toward less thrombus in EES than SES, in both ACS and SAP. Maximum color grade of the plaques was less advanced in EES than SES (p < 0.01). Yellow plaques of grade 2 or 3 were less frequent in EES than SES (35% vs 76%, p < 0.01). Conclusions: This study suggested that EES were associated with lower risk of thrombus formation than SES. (c) 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 22 条
[1]   Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents [J].
Awata, Masaki ;
Nanto, Shinsuke ;
Uematsu, Masaaki ;
Morozumi, Takakazu ;
Watanabe, Tetsuya ;
Onishi, Toshinari ;
Iida, Osamu ;
Sera, Fusako ;
Kotani, Jun-ichi ;
Hori, Masatsugu ;
Nagata, Seiki .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (09) :789-790
[2]   Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial [J].
Byrne, Robert A. ;
Kastrati, Adnan ;
Kufner, Sebastian ;
Massberg, Steffen ;
Birkmeier, K. Anette ;
Laugwitz, Karl-Ludwig ;
Schulz, Stefanie ;
Pache, Juergen ;
Fusaro, Massimiliano ;
Seyfarth, Melchior ;
Schoemig, Albert ;
Mehilli, Julinda .
EUROPEAN HEART JOURNAL, 2009, 30 (20) :2441-2449
[3]   Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials [J].
Cassese, Salvatore ;
Piccolo, Raffaele ;
Galasso, Gennaro ;
De Rosa, Roberta ;
Piscione, Federico .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) :84-89
[4]   Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].
Daemen, Joost ;
Wenaweser, Peter ;
Tsuchida, Keiichi ;
Abrecht, Linda ;
Sophia, Vaina ;
Morger, Cyrill ;
Kukreja, Neville ;
Jueni, Peter ;
Sianos, Georgios ;
Hellige, Gerrit ;
van Domburg, Ron T. ;
Hess, Otto M. ;
Boersma, Eric ;
Meier, Bernhard ;
Windecker, Stephan ;
Serruys, Patrick W. .
LANCET, 2007, 369 (9562) :667-678
[5]  
Dai K, 2010, EUROINTERVENTION, V6, P251, DOI 10.4244/
[6]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441
[7]  
Heifer PD, 1994, EUR HEART J, V15, P815
[8]   Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent An Angioscopic Study [J].
Higo, Tomoaki ;
Ueda, Yasunori ;
Oyabu, Jota ;
Okada, Katsuki ;
Nishio, Mayu ;
Hirata, Akio ;
Kashiwase, Kazunori ;
Ogasawara, Nobuyuki ;
Hirotani, Shinichi ;
Kodama, Kazuhisa .
JACC-CARDIOVASCULAR IMAGING, 2009, 2 (05) :616-624
[9]   Optical coherence evaluation of everolimus-eluting stents 8 months after implantation [J].
Inoue, Takumi ;
Shite, Junya ;
Yoon, Junghan ;
Shinke, Toshiro ;
Otake, Hiromasa ;
Sawada, Takahiro ;
Kawamori, Hiroyuki ;
Katoh, Hiroki ;
Miyoshi, Naoki ;
Yoshino, Naoki ;
Kozuki, Amane ;
Hariki, Hirotoshi ;
Hirata, Ken-ichi .
HEART, 2011, 97 (17) :1379-1384
[10]   Impaired Coronary Vasomotion After Coronary Intervention With Drug-Eluting Stents [J].
Ishihara, Masaharu .
CIRCULATION JOURNAL, 2010, 74 (11) :2293-2294